• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA 结合蛋白:血管功能障碍的新兴治疗靶点。

RNA-Binding Proteins: Emerging Therapeutics for Vascular Dysfunction.

机构信息

Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK.

出版信息

Cells. 2022 Aug 11;11(16):2494. doi: 10.3390/cells11162494.

DOI:10.3390/cells11162494
PMID:36010571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9407011/
Abstract

Vascular diseases account for a significant number of deaths worldwide, with cardiovascular diseases remaining the leading cause of mortality. This ongoing, ever-increasing burden has made the need for an effective treatment strategy a global priority. Recent advances in regenerative medicine, largely the derivation and use of induced pluripotent stem cell (iPSC) technologies as disease models, have provided powerful tools to study the different cell types that comprise the vascular system, allowing for a greater understanding of the molecular mechanisms behind vascular health. iPSC disease models consequently offer an exciting strategy to deepen our understanding of disease as well as develop new therapeutic avenues with clinical translation. Both transcriptional and post-transcriptional mechanisms are widely accepted to have fundamental roles in orchestrating responses to vascular damage. Recently, iPSC technologies have increased our understanding of RNA-binding proteins (RBPs) in controlling gene expression and cellular functions, providing an insight into the onset and progression of vascular dysfunction. Revelations of such roles within vascular disease states have therefore allowed for a greater clarification of disease mechanisms, aiding the development of novel therapeutic interventions. Here, we discuss newly discovered roles of RBPs within the cardio-vasculature aided by iPSC technologies, as well as examine their therapeutic potential, with a particular focus on the Quaking family of isoforms.

摘要

血管疾病在全球范围内造成了大量的死亡,心血管疾病仍然是主要的死亡原因。这种持续不断、日益增加的负担使得需要一种有效的治疗策略成为全球的优先事项。再生医学的最新进展,主要是诱导多能干细胞(iPSC)技术作为疾病模型的衍生和应用,为研究构成血管系统的不同细胞类型提供了强大的工具,使我们能够更好地了解血管健康背后的分子机制。因此,iPSC 疾病模型为我们提供了一种令人兴奋的策略,可以加深我们对疾病的理解,并开发具有临床转化的新治疗途径。转录和转录后机制都被广泛认为在协调对血管损伤的反应中起着基本作用。最近,iPSC 技术提高了我们对 RNA 结合蛋白(RBP)在控制基因表达和细胞功能中的作用的理解,深入了解了血管功能障碍的发生和进展。因此,在血管疾病状态下发现这些作用,使我们能够更好地阐明疾病机制,从而为新的治疗干预措施的发展提供帮助。在这里,我们讨论了 iPSC 技术辅助下心血管系统中 RBP 的新发现作用,并研究了它们的治疗潜力,特别关注 Quaking 家族同工型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d1/9407011/c26dae16f516/cells-11-02494-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d1/9407011/291f6857c249/cells-11-02494-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d1/9407011/1764141f7cc0/cells-11-02494-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d1/9407011/616f6f4c2ff5/cells-11-02494-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d1/9407011/c26dae16f516/cells-11-02494-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d1/9407011/291f6857c249/cells-11-02494-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d1/9407011/1764141f7cc0/cells-11-02494-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d1/9407011/616f6f4c2ff5/cells-11-02494-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d1/9407011/c26dae16f516/cells-11-02494-g004.jpg

相似文献

1
RNA-Binding Proteins: Emerging Therapeutics for Vascular Dysfunction.RNA 结合蛋白:血管功能障碍的新兴治疗靶点。
Cells. 2022 Aug 11;11(16):2494. doi: 10.3390/cells11162494.
2
Quaking Is a Key Regulator of Endothelial Cell Differentiation, Neovascularization, and Angiogenesis.震颤蛋白是内皮细胞分化、新血管形成和血管生成的关键调节因子。
Stem Cells. 2017 Apr;35(4):952-966. doi: 10.1002/stem.2594. Epub 2017 Mar 5.
3
The RNA-binding protein QKI controls alternative splicing in vascular cells, producing an effective model for therapy.RNA 结合蛋白 QKI 控制血管细胞中的可变剪接,为治疗提供了有效的模型。
J Cell Sci. 2019 Aug 15;132(16):jcs230276. doi: 10.1242/jcs.230276.
4
Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype.颤抖蛋白,一种 RNA 结合蛋白,是血管平滑肌细胞表型的关键调节因子。
Circ Res. 2013 Oct 12;113(9):1065-75. doi: 10.1161/CIRCRESAHA.113.301302. Epub 2013 Aug 20.
5
Genome Editing and Induced Pluripotent Stem Cell Technologies for Personalized Study of Cardiovascular Diseases.基因组编辑和诱导多能干细胞技术在心血管疾病个体化研究中的应用。
Curr Cardiol Rep. 2018 Apr 17;20(6):38. doi: 10.1007/s11886-018-0984-9.
6
Induced pluripotent stem cell-derived vascular smooth muscle cells: methods and application.诱导多能干细胞衍生的血管平滑肌细胞:方法与应用
Biochem J. 2015 Jan 15;465(2):185-94. doi: 10.1042/BJ20141078.
7
Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.携带有 RBM20 突变 S635A 的患者表现出严重的扩张型心肌病表型,可以通过患者特异性诱导多能干细胞衍生的心肌细胞来模拟。
J Mol Cell Cardiol. 2017 Dec;113:9-21. doi: 10.1016/j.yjmcc.2017.09.008. Epub 2017 Sep 21.
8
Stress-Specific Spatiotemporal Responses of RNA-Binding Proteins in Human Stem-Cell-Derived Motor Neurons.应激特异性 RNA 结合蛋白在人干细胞衍生运动神经元中的时空反应。
Int J Mol Sci. 2020 Nov 6;21(21):8346. doi: 10.3390/ijms21218346.
9
Induced pluripotent stem cells for regenerative cardiovascular therapies and biomedical discovery.诱导多能干细胞在再生心血管疗法和生物医学发现中的应用。
Adv Drug Deliv Rev. 2011 Apr 30;63(4-5):324-30. doi: 10.1016/j.addr.2011.01.013. Epub 2011 Mar 1.
10
Induced pluripotent stem cell technology: a decade of progress.诱导多能干细胞技术:十年进展
Nat Rev Drug Discov. 2017 Feb;16(2):115-130. doi: 10.1038/nrd.2016.245. Epub 2016 Dec 16.

引用本文的文献

1
Biological function of RNA-binding proteins in myocardial infarction: a potential emerging therapeutic limelight.RNA结合蛋白在心肌梗死中的生物学功能:一个潜在的新兴治疗焦点。
Cell Biosci. 2025 May 24;15(1):65. doi: 10.1186/s13578-025-01408-8.
2
Metabolic and Mitochondrial Dysregulations in Diabetic Cardiac Complications.糖尿病心脏并发症中的代谢和线粒体功能失调
Int J Mol Sci. 2025 Mar 26;26(7):3016. doi: 10.3390/ijms26073016.
3
RNA-binding protein quaking: a multifunctional regulator in tumour progression.RNA结合蛋白震颤蛋白:肿瘤进展中的多功能调节因子

本文引用的文献

1
Platelet SHARPIN regulates platelet adhesion and inflammatory responses through associations with αIIbβ3 and LUBAC.血小板 SHARPIN 通过与 αIIbβ3 和 LUBAC 的关联调节血小板黏附和炎症反应。
Blood Adv. 2022 Apr 26;6(8):2595-2607. doi: 10.1182/bloodadvances.2021005611.
2
Alternative Splicing: A Key Mediator of Diabetic Vasculopathy.选择性剪接:糖尿病血管病变的关键调节因子。
Genes (Basel). 2021 Aug 27;12(9):1332. doi: 10.3390/genes12091332.
3
RNA-Binding Proteins Hold Key Roles in Function, Dysfunction, and Disease.RNA结合蛋白在功能、功能障碍和疾病中发挥关键作用。
Ann Med. 2025 Dec;57(1):2443046. doi: 10.1080/07853890.2024.2443046. Epub 2024 Dec 23.
4
Rbm24-mediated post-transcriptional regulation of skeletal and cardiac muscle development, function and regeneration.Rbm24介导的骨骼肌和心肌发育、功能及再生的转录后调控
J Muscle Res Cell Motil. 2025 Mar;46(1):53-65. doi: 10.1007/s10974-024-09685-5. Epub 2024 Nov 30.
5
The Biological Mechanisms and Clinical Roles of RNA-Binding Proteins in Cardiovascular Diseases.RNA 结合蛋白在心血管疾病中的生物学机制和临床作用。
Biomolecules. 2024 Aug 25;14(9):1056. doi: 10.3390/biom14091056.
6
RNA-binding proteins in bone pathophysiology.骨病理生理学中的RNA结合蛋白
Front Cell Dev Biol. 2024 Jun 20;12:1412268. doi: 10.3389/fcell.2024.1412268. eCollection 2024.
7
RNA binding proteins as mediators of pathological cardiac remodeling.RNA结合蛋白作为病理性心脏重塑的介质
Front Cell Dev Biol. 2024 May 16;12:1368097. doi: 10.3389/fcell.2024.1368097. eCollection 2024.
8
RNA-Binding Proteins in Cardiomyopathies.心肌病中的RNA结合蛋白
J Cardiovasc Dev Dis. 2024 Mar 5;11(3):88. doi: 10.3390/jcdd11030088.
9
Identification and validation of RNA-binding protein SLC3A2 regulates melanocyte ferroptosis in vitiligo by integrated analysis of single-cell and bulk RNA-sequencing.通过单细胞和批量 RNA 测序的综合分析鉴定和验证 RNA 结合蛋白 SLC3A2 调控白癜风黑素细胞铁死亡
BMC Genomics. 2024 Mar 4;25(1):236. doi: 10.1186/s12864-024-10147-y.
10
Unraveling the Role of RNA-Binding Proteins, with a Focus on RPS5, in the Malignant Progression of Hepatocellular Carcinoma.解析 RNA 结合蛋白(以 RPS5 为例)在肝细胞癌恶性进展中的作用。
Int J Mol Sci. 2024 Jan 7;25(2):773. doi: 10.3390/ijms25020773.
Biology (Basel). 2021 Apr 24;10(5):366. doi: 10.3390/biology10050366.
4
RNA-Binding Proteins as Regulators of Migration, Invasion and Metastasis in Oral Squamous Cell Carcinoma.RNA 结合蛋白作为口腔鳞状细胞癌迁移、侵袭和转移的调节剂。
Int J Mol Sci. 2020 Sep 17;21(18):6835. doi: 10.3390/ijms21186835.
5
Targeting QKI-7 in vivo restores endothelial cell function in diabetes.在体内靶向 QKI-7 可恢复糖尿病中的内皮细胞功能。
Nat Commun. 2020 Jul 30;11(1):3812. doi: 10.1038/s41467-020-17468-y.
6
A large-scale binding and functional map of human RNA-binding proteins.人类 RNA 结合蛋白的大规模结合和功能图谱。
Nature. 2020 Jul;583(7818):711-719. doi: 10.1038/s41586-020-2077-3. Epub 2020 Jul 29.
7
Modeling Type 1 Diabetes In Vitro Using Human Pluripotent Stem Cells.利用人类多能干细胞体外建模 1 型糖尿病。
Cell Rep. 2020 Jul 14;32(2):107894. doi: 10.1016/j.celrep.2020.107894.
8
HuR (Human Antigen R) Regulates the Contraction of Vascular Smooth Muscle and Maintains Blood Pressure.HuR(人类抗原 R)调节血管平滑肌的收缩并维持血压。
Arterioscler Thromb Vasc Biol. 2020 Apr;40(4):943-957. doi: 10.1161/ATVBAHA.119.313897. Epub 2020 Feb 20.
9
RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs.基于 RNA 的治疗学:从反义寡核苷酸到 miRNA。
Cells. 2020 Jan 7;9(1):137. doi: 10.3390/cells9010137.
10
oRNAment: a database of putative RNA binding protein target sites in the transcriptomes of model species.oRNAment:模式物种转录组中假定 RNA 结合蛋白靶位的数据库。
Nucleic Acids Res. 2020 Jan 8;48(D1):D166-D173. doi: 10.1093/nar/gkz986.